Skip to main content

Garth S Herbert, MD

Assistant Professor of Surgery
Office: 3404 Wake Forest Rd, Suite 303, Raleigh, NC 27609

Education and Training

  • Complex General Surgical Oncology Fellow, Surgery, Memorial Sloan-Kettering Cancer Center, 2013 - 2015
  • General Surgery Resident, Surgery, Madigan Army Medical Center, 2003 - 2009
  • M.D., Yale University School of Medicine, 2003
  • B.S., United States Military Academy, 1995

Publications

Brown, Tommy A., Kevin Byrd, Timothy J. Vreeland, Guy T. Clifton, Doreen O. Jackson, Diane F. Hale, Garth S. Herbert, et al. “Final analysis of a phase I/IIa trial of the folate-binding protein-derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patients.” Cancer Med 8, no. 10 (August 2019): 4678–87. https://doi.org/10.1002/cam4.2378.

Full Text

Clifton, G Travis, Kaitlin M. Peace, Jarrod P. Holmes, Timothy J. Vreeland, Diane F. Hale, Garth S. Herbert, Jennifer K. Litton, et al. “Initial safety analysis of a randomized phase II trial of nelipepimut-S + GM-CSF and trastuzumab compared to trastuzumab alone to prevent recurrence in breast cancer patients with HER2 low-expressing tumors.” Clin Immunol 201 (April 2019): 48–54. https://doi.org/10.1016/j.clim.2019.02.011.

Full Text

Herbert, Garth S., Timothy J. Vreeland, Guy T. Clifton, Julia M. Greene, Doreen O. Jackson, Mark O. Hardin, Diane F. Hale, et al. “Initial phase I/IIa trial results of an autologous tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine in patients with solid tumors.” Vaccine 36, no. 23 (May 31, 2018): 3247–53. https://doi.org/10.1016/j.vaccine.2018.04.078.

Full Text

Hardin, Mark O., Timothy J. Vreeland, Guy T. Clifton, Diane F. Hale, Garth S. Herbert, Julia M. Greene, Doreen O. Jackson, et al. “Tumor lysate particle loaded dendritic cell vaccine: preclinical testing of a novel personalized cancer vaccine.” Immunotherapy 10, no. 5 (April 2018): 373–82. https://doi.org/10.2217/imt-2017-0114.

Full Text

Herbert, Garth, Giorgos C. Karakousis, Edmund K. Bartlett, Salman Zaheer, Danielle Graham, Brian J. Czerniecki, Douglas L. Fraker, Charlotte Ariyan, Daniel G. Coit, and Mary S. Brady. “Transected thin melanoma: Implications for sentinel lymph node staging.” J Surg Oncol 117, no. 4 (March 2018): 567–71. https://doi.org/10.1002/jso.24930.

Full Text

Berry, John, Timothy Vreeland, Alfred Trappey, Diane Hale, Kaitlin Peace, Joshua Tyler, Avery Walker, et al. “Cancer vaccines in colon and rectal cancer over the last decade: lessons learned and future directions.” Expert Review of Clinical Immunology 13, no. 3 (March 2017): 235–45. https://doi.org/10.1080/1744666x.2016.1226132.

Full Text

Berry, J. S., T. J. Vreeland, D. F. Hale, D. O. Jackson, A. F. Trappey, J. M. Greene, M. O. Hardin, G. S. Herbert, G. T. Clifton, and G. E. Peoples. “Evaluation of attenuated tumor antigens and the implications for peptide-based cancer vaccine development.” Journal of Cancer 8, no. 7 (January 1, 2017): 1255–62. https://doi.org/10.7150/jca.16450.

Full Text

Jackson, D. O., K. Byrd, T. J. Vreeland, D. F. Hale, G. S. Herbert, J. M. Greene, E. J. Schneble, et al. “Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients.” Oncotarget 8, no. 9 (January 1, 2017): 15912–23. https://doi.org/10.18632/oncotarget.13305.

Full Text

Pages